J. Sánchez de Toledo

发表

SIOP MMT 95: Intensified (6 drug) versus standard (IVA) chemotherapy for high risk non metastatic rhabdomyosarcoma (RMS).

O. Oberlin, C. Ellershaw, A. Rey, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.

M. Stevens, A. Kelsey, J. Merks, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloproliferative Disorder in Noonan Syndrome

B. Ezquieta, S. García-Miñaúr, J. Dapena, 2011, Journal of pediatric hematology/oncology.

[Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].

T. Olivé, A. Llort, C. Díaz de Heredia, 2013, Anales de pediatria.

Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology.

C. Haie-meder, M. Stevens, M. Terrier-Lacombe, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimization of rhabdomyosarcoma disseminated disease assessment by flow cytometry

M. Segura, J. Roma, A. Llort, 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[Treatment of neuroblastoma].

J. Sánchez de Toledo, G. Javier, J. Prats, 1991, Medicina clinica.

Post‐transplant lymphoproliferative disorders in children: The role of chemotherapy in the era of rituximab

J. Bueno, A. Llort, S. Gallego, 2010, Pediatric transplantation.

Non-Hodgkin's lymphoma after liver transplantation: response to chemotherapy.

E. Allende, F. Moraga, J. Iglesias, 1996, Medical and pediatric oncology.

Infantile fibrosarcoma of femur.

J. Lucaya, J. Sánchez de Toledo, L. Bernadó, 1987, Pediatric pathology.

Notch Pathway Inhibition Significantly Reduces Rhabdomyosarcoma Invasiveness and Mobility In Vitro

J. Reventós, J. Roma, S. Gallego, 2010, Clinical Cancer Research.

Neuronal Differentiation-Related Epigenetic Regulator ZRF1 Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro

M. Segura, J. Camacho, D. Llobet-Navás, 2021, Cancers.

Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon

J. Roma, G. Gallo-Oller, S. Gallego, 2022, bioRxiv.

[Novel micro RNA-based therapies for the treatment of neuroblastoma].

M. Segura, J. Roma, A. Soriano, 2016, Anales de pediatria.

Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.

D. Orbach, M. Terrier-Lacombe, O. Oberlin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research.

J. Wingard, E. Horwitz, A. Filipovich, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Role of Leptin in Diencephalic Syndrome

M. Clemente, S. Gallego, J. Sánchez de Toledo, 2014, Pediatrics.

Targeting the Hedgehog Pathway in Rhabdomyosarcoma

M. Segura, J. Roma, G. Gallo-Oller, 2023, Cancers.

The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis

J. Lizcano, M. Segura, M. Yeste-Velasco, 2020, Cell Death & Disease.

The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models

A. Villanueva, M. Segura, R. Noguera, 2021, Clinical and translational medicine.

[Primary cervical tumors of the sympathetic nervous system. Report of 8 cases].

R. Balcells, J. Sánchez de Toledo, L. Sanchís, 1989, Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica.

Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer

M. Segura, J. Roma, A. Soriano, 2019, Front. Oncol..

Notch, Wnt, and Hedgehog Pathways in Rhabdomyosarcoma: From Single Pathways to an Integrated Network

J. Roma, S. Gallego, J. Sánchez de Toledo, 2012, Sarcoma.

Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia

E. Lopez-Lopez, A. Navajas, J. Ballesteros, 2013, Pharmacogenetics and genomics.

Clinical and radiographic response of Langerhans' cell histiocytosis with chemotherapy

J. Carreño, F. Moraga, J. Sánchez de Toledo, 2004, Neuroradiology.

CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models

M. Segura, M. Martini, R. Riccardi, 2020, Cancers.

Wilms' tumours with intracaval involvement.

A. Castellote, M. D. de Diego, V. Martínez-Ibáñez, 1996, Medical and pediatric oncology.

Surviving Childhood Cancer: Relationship between Exercise and Coping on Quality of Life

L. Capdevila, S. Gallego, T. Blasco, 2013, The Spanish Journal of Psychology.

Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands

S. Navarro, H. Hahn, J. Pyczek, 2017, British Journal of Cancer.

Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma

M. Segura, A. Alfranca, J. García-Castro, 2017, Stem cells international.

Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.

H. B. Marsden, M. Stevens, H. Marsden, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma.

J. Roma, G. Gallo-Oller, A. Soriano, 2020, Cancer letters.

Natural killer cell function in children with malignant solid neoplasias.

J. Sánchez de Toledo, S. Gallego-Melcón, J. P. Prats Viñas, 1991, Medical and pediatric oncology.

Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology.

V. Castel, A. Llombart, J. Ruiz-Jiménez, 1995, Medical and pediatric oncology.

[Primitive neuroectodermal tumors: difficult tumors versus modern oncology].

N. Torán, J. Sánchez de Toledo, J. Boix-Ochoa, 1998, Cirugía pediátrica.

Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role

M. Segura, J. Roma, G. Gallo-Oller, 2021, Pharmaceuticals.

[Infantile hepatic hemangioendothelioma of the liver: report of 11 cases].

A. Castellote, V. Martínez-Ibáñez, J. Sánchez de Toledo, 1996, Cirugía pediátrica.

Childhood soft tissue sarcomas incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project.

E. Steliarova-Foucher, M. Carli, G. Pastore, 2006, European journal of cancer.

[Survival analysis of hematopoietic stem cell transplantation in children with primary immunodeficiency in Spain].

I. Badell, C. Díaz de Heredia, I. Elorza, 2015, Anales de pediatria.

Compassionate Use Study of Caspofungin in Children with Proven or Suspected Invasive Mycosis or Persistent Febrile Neutropenia

L. Madero, V. Castel, J. Sevilla, 2009, Journal of chemotherapy.

Expression of multidrug resistance-1 and multidrug resistance-associated protein genes in pediatric rhabdomyosarcoma.

A. Llort, S. Gallego, J. Sánchez de Toledo, 2004, Oncology reports.

[Focal nodular hyperplasia].

I. Roca, A. Castellote, F. Moraga, 1993, Anales espanoles de pediatria.

Improving survival of medulloblastoma: results in two groups of patients.

J. Giralt, X. Maldonado, S. Gallego, 1996, Oncology.

Characterisation of novel splicing variants of the tyrosine hydroxylase C-terminal domain in human neuroblastic tumours

E. Saus, J. Reventós, J. Roma, 2007, Biological chemistry.

Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo

D. Arango, M. Segura, J. Roma, 2021, International journal of molecular sciences.

Perceived positive and negative consequences after surviving cancer and their relation to quality of life.

C. Castellano-Tejedor, L. Capdevila, F. Eiroa-Orosa, 2015, Scandinavian journal of psychology.

Late recurrent metastasis in Wilms' tumour.

F. Moraga, J. Sánchez de Toledo, D. Lopez, 1994, Medical and pediatric oncology.

Title: Notch Pathway Inhibition Significantly Reduces Rhabdomyosarcoma Invasiveness and Mobility in Vitro

J. Reventós, J. Roma, S. Gallego, 2022 .

Clinical relevance of molecular markers in neuroblastoma: results from a single institution.

J. Reventós, F. Munell, S. Gallego, 1999, Oncology reports.

Successful Treatment of Sinusitis by Acanthamoeba in a Pediatric Patient After Allogeneic Stem Cell Transplantation.

E. Sulleiro, C. Díaz de Heredia, J. Sánchez de Toledo, 2016, The Pediatric infectious disease journal.